-
1
-
-
0027571473
-
Small cell lung cancer: Etiology, biology, clinical features, staging, and treatment
-
Cook RM, Miller YE and Bunn PA Jr: Small cell lung cancer: etiology, biology, clinical features, staging, and treatment. Current Problems in Cancer XVII: 71-141, 1993.
-
(1993)
Current Problems in Cancer
, vol.17
, pp. 71-141
-
-
Cook, R.M.1
Miller, Y.E.2
Bunn Jr., P.A.3
-
2
-
-
0002173310
-
Neuroendocrine (NE) tumors of the lung
-
Gazdar AF and Carbone DP, eds. Austin/Georgetown, R.G. Landes Company
-
Gazdar AF and Carbone DP: Neuroendocrine (NE) tumors of the lung. In: The biology and molecular genetics of lung cancer (Gazdar AF and Carbone DP, eds). Austin/Georgetown, R.G. Landes Company, pp 16-26, 1994.
-
(1994)
The Biology and Molecular Genetics of Lung Cancer
, pp. 16-26
-
-
Gazdar, A.F.1
Carbone, D.P.2
-
3
-
-
0027331858
-
The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types
-
Prins J, De Vries EGE and Mulder NH: The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types. Anticancer Res 13: 1373-1386, 1993.
-
(1993)
Anticancer Res
, vol.13
, pp. 1373-1386
-
-
Prins, J.1
De Vries, E.G.E.2
Mulder, N.H.3
-
4
-
-
0023020262
-
The myc oncogene: Its role in transformation and differentiation
-
Cole MD: The myc oncogene: its role in transformation and differentiation. Ann Rev Genet 20: 361-384, 1986.
-
(1986)
Ann Rev Genet
, vol.20
, pp. 361-384
-
-
Cole, M.D.1
-
5
-
-
0026705929
-
Max and c-Myc/Max DNA-binding activities in cell extracts
-
Littlewood TD, Amati B, Land H and Evan GI: Max and c-Myc/Max DNA-binding activities in cell extracts. Oncogene 7: 1783-1792, 1992.
-
(1992)
Oncogene
, vol.7
, pp. 1783-1792
-
-
Littlewood, T.D.1
Amati, B.2
Land, H.3
Evan, G.I.4
-
7
-
-
0025730938
-
Modulation of cis-platinum resistance in Friend erythroleukemia cells by c-myc
-
Sklar MD and Prochownik EV: Modulation of cis-platinum resistance in Friend erythroleukemia cells by c-myc. Cancer Res 51: 2118-2123, 1991.
-
(1991)
Cancer Res
, vol.51
, pp. 2118-2123
-
-
Sklar, M.D.1
Prochownik, E.V.2
-
8
-
-
0026065699
-
Resistance to anticancer drugs in NIHT3T3 cells transfected with c-myc and/or c-H-ras genes
-
Niimi S, Nakagawa K, Yokota J, Tsunokawa Y, Nishio K, Terashima Y, Shibuya M, Terada M and Sajio N: Resistance to anticancer drugs in NIHT3T3 cells transfected with c-myc and/or c-H-ras genes. Br J Cancer 63: 237-241, 1991.
-
(1991)
Br J Cancer
, vol.63
, pp. 237-241
-
-
Niimi, S.1
Nakagawa, K.2
Yokota, J.3
Tsunokawa, Y.4
Nishio, K.5
Terashima, Y.6
Shibuya, M.7
Terada, M.8
Sajio, N.9
-
9
-
-
0029763897
-
Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines
-
Van Waardenburg RCAM, Prins J, Meijer C, Uges DRA, De Vries EGE and Mulder NH: Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines. Anticancer Res 16: 1963-1970, 1996.
-
(1996)
Anticancer Res
, vol.16
, pp. 1963-1970
-
-
Van Waardenburg, R.C.A.M.1
Prins, J.2
Meijer, C.3
Uges, D.R.A.4
De Vries, E.G.E.5
Mulder, N.H.6
-
10
-
-
0031465779
-
Effects of an inducible antisense c-myc gene transfer in a drug resistant human small cell lung carcinoma cell line
-
in press
-
Van Waardenburg RCAM, Meijer C, De Jong S, Burger H, Nooter K, De Vries EGE and Mulder NH: Effects of an inducible antisense c-myc gene transfer in a drug resistant human small cell lung carcinoma cell line. Int J Cancer in press, 1997.
-
(1997)
Int J Cancer
-
-
Van Waardenburg, R.C.A.M.1
Meijer, C.2
De Jong, S.3
Burger, H.4
Nooter, K.5
De Vries, E.G.E.6
Mulder, N.H.7
-
11
-
-
0002651205
-
Monoclonal antibodies in clinical and experimental pathology of lung cancer
-
Ruiter DJ, Fleuren GJ and Warnaar SO, eds. Dordrecht, Boston, Lancaster, Martinus Nijhoff Publishers
-
De Leij L, Broers J, Ramaekers F, Berendsen H and Wagenaar Sj Sc: Monoclonal antibodies in clinical and experimental pathology of lung cancer. In: Application of monoclonal antibodies in tumour pathology (Ruiter DJ, Fleuren GJ and Warnaar SO, eds). Dordrecht, Boston, Lancaster, Martinus Nijhoff Publishers, pp 190-210, 1986.
-
(1986)
Application of Monoclonal Antibodies in Tumour Pathology
, pp. 190-210
-
-
De Leij, L.1
Broers, J.2
Ramaekers, F.3
Berendsen, H.4
Wagenaar, Sj.Sc.5
-
12
-
-
0024264934
-
Characterization of a human small cell lung carcinoma cell line with acquired cisplatin resistance in vitro
-
Hospers GAP, Mulder NH, De Jong B, De Leij L, Uges DRA, Fichtinger-Schepman AMJ, Scheper RJ and De Vries EGE: Characterization of a human small cell lung carcinoma cell line with acquired cisplatin resistance in vitro. Cancer Res 48: 6803-6807, 1988.
-
(1988)
Cancer Res
, vol.48
, pp. 6803-6807
-
-
Hospers, G.A.P.1
Mulder, N.H.2
De Jong, B.3
De Leij, L.4
Uges, D.R.A.5
Fichtinger-Schepman, A.M.J.6
Scheper, R.J.7
De Vries, E.G.E.8
-
13
-
-
0025353691
-
Cellular pharmacology of cisplatin: Perspectives on mechanisms of acquired resistance
-
Andrews PA and Howell SB: Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 2: 35-43, 1990.
-
(1990)
Cancer Cells
, vol.2
, pp. 35-43
-
-
Andrews, P.A.1
Howell, S.B.2
-
14
-
-
0027120232
-
P-Glycoprotein and resistance to anticancer drugs
-
Ling V: P-Glycoprotein and resistance to anticancer drugs. Cancer 69: 2603-2609, 1992,
-
(1992)
Cancer
, vol.69
, pp. 2603-2609
-
-
Ling, V.1
-
15
-
-
0027095653
-
Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
-
Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Steward AJ, Kurz EU, Duncan AMV and Deeley RG: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654, 1992.
-
(1992)
Science
, vol.258
, pp. 1650-1654
-
-
Cole, S.P.C.1
Bhardwaj, G.2
Gerlach, J.H.3
Mackie, J.E.4
Grant, C.E.5
Almquist, K.C.6
Steward, A.J.7
Kurz, E.U.8
Duncan, A.M.V.9
Deeley, R.G.10
-
16
-
-
0025569131
-
The role of detoxifying systems in resistance of tumour cells to cisplatin and adriamycin. A review
-
Meijer C, Mulder NH and De Vries EGE: The role of detoxifying systems in resistance of tumour cells to cisplatin and adriamycin. A review. Cancer Treat Rev 17: 389-407, 1990.
-
(1990)
Cancer Treat Rev
, vol.17
, pp. 389-407
-
-
Meijer, C.1
Mulder, N.H.2
De Vries, E.G.E.3
-
17
-
-
0025162113
-
Reduced DNA topoisomerase II activity in an adriamycin-resistant human small cell lung carcinoma cell line
-
De Jong S, Zijlstra JG, De Vries EGE and Mulder NH: Reduced DNA topoisomerase II activity in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res 50: 304-309, 1990.
-
(1990)
Cancer Res
, vol.50
, pp. 304-309
-
-
De Jong, S.1
Zijlstra, J.G.2
De Vries, E.G.E.3
Mulder, N.H.4
-
18
-
-
0021053735
-
Amplification and expression of the c-myc oncogene in human lung cancer cell lines
-
Little CD, Bau MM, Carney DN, Gazdar AF and Minna JD: Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 306: 194-196, 1983.
-
(1983)
Nature
, vol.306
, pp. 194-196
-
-
Little, C.D.1
Bau, M.M.2
Carney, D.N.3
Gazdar, A.F.4
Minna, J.D.5
-
19
-
-
0026463349
-
Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines
-
Gazdar AF, Kadoyama C, Venzon D, Park JG, Tsai CM, Linnoila RI, Mulshine JL, Ihde DC and Giaccone G: Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines. Monogr Natl Cancer Inst 13: 191-196, 1992.
-
(1992)
Monogr Natl Cancer Inst
, vol.13
, pp. 191-196
-
-
Gazdar, A.F.1
Kadoyama, C.2
Venzon, D.3
Park, J.G.4
Tsai, C.M.5
Linnoila, R.I.6
Mulshine, J.L.7
Ihde, D.C.8
Giaccone, G.9
-
20
-
-
0029064674
-
Biological and molecular prognostic factors - Impact on treatment of patients with non-small cell lung cancer
-
Johnson BE: Biological and molecular prognostic factors - impact on treatment of patients with non-small cell lung cancer. Chest 107 (6 Suppl): 287S-290S, 1995.
-
(1995)
Chest
, vol.107
, Issue.6 SUPPL.
-
-
Johnson, B.E.1
-
21
-
-
0021611174
-
Antibodies to intermediate filament proteins in the diagnosis and classification of human tumors
-
Miettinen M, Lehto V-P and Virtanen I: Antibodies to intermediate filament proteins in the diagnosis and classification of human tumors. Ultrastructural Pathology 7: 83-107, 1984.
-
(1984)
Ultrastructural Pathology
, vol.7
, pp. 83-107
-
-
Miettinen, M.1
Lehto, V.-P.2
Virtanen, I.3
-
22
-
-
0028901404
-
Different vimentin expression in two clones derived from a human colocarcinoma cell line (LoVo) showing different sensitivity to doxorubicin
-
Conforti G, Codegoni AM, Scanziani E, Dolfini E, Dasdia T, Calza M, Caniatti M and Broggini M: Different vimentin expression in two clones derived from a human colocarcinoma cell line (LoVo) showing different sensitivity to doxorubicin. Br J Cancer 71: 505-511, 1995.
-
(1995)
Br J Cancer
, vol.71
, pp. 505-511
-
-
Conforti, G.1
Codegoni, A.M.2
Scanziani, E.3
Dolfini, E.4
Dasdia, T.5
Calza, M.6
Caniatti, M.7
Broggini, M.8
-
23
-
-
0026503479
-
Heat-resistant variants of the Chinese hamster ovary cell: Alteration of cellular structure and expression of vimentin
-
Lee YJ, Hou ZZ, Curetty L, Armour EP, Saadi A, Bernstein J and Corry PM: Heat-resistant variants of the Chinese hamster ovary cell: alteration of cellular structure and expression of vimentin. J Cell Physiol 151: 138-146, 1992.
-
(1992)
J Cell Physiol
, vol.151
, pp. 138-146
-
-
Lee, Y.J.1
Hou, Z.Z.2
Curetty, L.3
Armour, E.P.4
Saadi, A.5
Bernstein, J.6
Corry, P.M.7
-
24
-
-
0025907505
-
Differentiation of human promonocytic leukemia U-937 cells with DNA topoisomerase II inhibitors: Induction of vimentin gene expression
-
Rius C, Zorrilla AR, Cabanas C, Mata F, Bernabeu C and Aller P: Differentiation of human promonocytic leukemia U-937 cells with DNA topoisomerase II inhibitors: induction of vimentin gene expression. Mol Pharmacol 39: 442-448, 1991.
-
(1991)
Mol Pharmacol
, vol.39
, pp. 442-448
-
-
Rius, C.1
Zorrilla, A.R.2
Cabanas, C.3
Mata, F.4
Bernabeu, C.5
Aller, P.6
-
25
-
-
0025210521
-
Ratios between the abundance of messenger RNA and the corresponding protein of two growth-related genes, c-myc and vimentin, in leukemia blast cells
-
Ferrari S, Tagliafico E, D'Inca M, Ceccherelli G, Manfredini R, Selleri L, Donelli A, Sacchi S, Torelli G and Torelli U: Ratios between the abundance of messenger RNA and the corresponding protein of two growth-related genes, c-myc and vimentin, in leukemia blast cells. Cancer Res 50: 1988-1991, 1990.
-
(1990)
Cancer Res
, vol.50
, pp. 1988-1991
-
-
Ferrari, S.1
Tagliafico, E.2
D'Inca, M.3
Ceccherelli, G.4
Manfredini, R.5
Selleri, L.6
Donelli, A.7
Sacchi, S.8
Torelli, G.9
Torelli, U.10
|